L. Sun

机构：University of Toronto, Public Health Ontario

发表论文 7 篇 · 总被引 4 次 · h-index 1

代表论文

• 1166P A phase I study of JS207, a PD-1/VEGF bispecific antibody, in patients with advanced malignancies (2025 · Annals of Oncology · 被引 2)
• LBA11 A phase II clinical study of dose optimization for ZG006 (Alveltamig) in patients with advanced small cell lung cancer who have received at least two prior lines of therapy (ZG006-002) (2025 · Annals of Oncology · 被引 1)
• An improved statistical framework for the HeTerogeneity Average (HTA) Index (2026 · Spatial Statistics)
• 984P Patient-relevant outcomes (PROs) from SACHI: A phase 3 trial of savolitinib (Savo) plus osimertinib (Osi) versus chemotherapy (Chemo) in EGFR-mutant (EGFRm) and MET-amplified (METamp) advanced NSCLC after progression on EGFR-TKIs (2025 · Annals of Oncology)
• 929MO Becotatug (JMT101, Beco) combined with docetaxel (albumin-bound, HB1801) for the treatment of patients (pts) with locally advanced squamous cell non-small cell lung cancer (sqNSCLC): A randomized control phase II study (BATTLE study) (2025 · Annals of Oncology)
• 1002P Progression pattern in patients (pts) with EGFR-mutant (EGFRm), MET-amplified (METamp) advanced NSCLC treated with savolitinib (savo) plus osimertinib (osi) (2025 · Annals of Oncology)